15Jan
BIVDA response to Parliament’s vote on the Brexit deal
Today the House of Commons voted down the EU withdrawal agreement and the framework for the future relationship.
Doris-Ann Williams, BIVDA’s Chief Executive, commented: “Today’s vote casts a shadow of uncertainty over the UK’s future relationship with the EU. The IVD industry remains anxious about access for patients to essential diagnostic tests if there is no transition period after 29 March. We therefore call for positive steps to be taken in these testing times and urge Government and policy makers to provide clarity and create sufficient space for our sector so that it is able to meet the significant challenge of ensuring the supply of essential diagnostics tests to patients through 2019.”
For a copy of BIVDA's position paper on Brexit, click here.
Related
BIVDA, ABPI and CRUK have released a stakeholder briefing to clarify the new arrangements for commis...
Read More >
Twickenham, UK – 11th October, 2018 – Lab Innovations, the UK’s only trade show dedicated to the ...
Read More >
IVD Market Statistics Report 2017 highlights differences in total healthcare expenditure and wide va...
Read More >
The productivity of the UK’s Life Sciences sector is more than double the UK average, says a new re...
Read More >
The Government has today (04 November) published its response to the final report of the Accelerated...
Read More >
Darren Stenlake (Sysmex UK Ltd) has been elected as Chairman of the BIVDA Board
Read More >